{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD",
    "Taisho Pharmaceutical R&D Inc., Morristown, NJ",
    "Taisho Pharmaceutical Co., Ltd., Tokyo, Japan"
  ],
  "article_type": "brief report",
  "arxiv": null,
  "author_total": 13,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Mark D. Kvarta",
      "orcid": "0000-0002-1093-1648"
    },
    {
      "affs": [
        1,
        2
      ],
      "name": "Mai Watanabe"
    },
    {
      "affs": [
        1,
        2
      ],
      "name": "Satoshi Ozaki"
    },
    {
      "affs": [
        0
      ],
      "name": "Dede Greenstein"
    },
    {
      "affs": [
        0
      ],
      "name": "Adam Fijtman",
      "orcid": "0000-0002-7700-4283"
    },
    {
      "affs": [
        0
      ],
      "name": "Gregory Jones"
    },
    {
      "affs": [
        0
      ],
      "name": "Hiroe I. Hu",
      "orcid": "0000-0003-1587-2736"
    },
    {
      "affs": [
        0
      ],
      "name": "Solaleh Azimipour",
      "orcid": "0009-0007-8912-3005"
    },
    {
      "affs": [
        0
      ],
      "name": "Peixiong Yuan"
    },
    {
      "affs": [
        0
      ],
      "name": "Jenessa N. Johnston"
    },
    {
      "affs": [
        0
      ],
      "name": "Jennifer W. Evans"
    },
    {
      "affs": [
        0
      ],
      "name": "Jessica R. Gilbert"
    },
    {
      "affs": [
        0
      ],
      "name": "Carlos A. Zarate",
      "orcid": "0000-0003-4442-7412"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7psp3qmnbwbk2.bib",
  "cited_by": 0,
  "doi": "10.1097/jcp.0000000000002246",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13716307/",
  "id": "7psp3qmnbwbk2",
  "issns": [
    "0271-0749",
    "1533-712X"
  ],
  "landing_url": "https://doi.org/10.1097/jcp.0000000000002246",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Brief Report"
    ],
    [
      "openalex",
      "2736|Treatment of Major Depression"
    ]
  ],
  "openalex": "W7211915078",
  "pdf_url": null,
  "pmcid": "PMC13716307",
  "pmid": "42704784",
  "published": "2026-09-07",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/7psp3qmnbwbk2.ris",
  "sources": [
    {
      "first_seen": "2026-11-01T12:23:20Z",
      "native_id": "PMC13716307",
      "source": "pmc",
      "url": "https://doi.org/10.1097/jcp.0000000000002246"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2736|Treatment of Major Depression",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression",
  "title_text": "The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression",
  "type": "peer-reviewed",
  "updated_at": "2026-11-01T12:23:20Z",
  "url": "https://research.draconitic.com/paper/7psp3qmnbwbk2",
  "venue": "Journal of Clinical Psychopharmacology",
  "versions": []
}